Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M | Fierce Pharma
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
/cloudfront-us-east-1.images.arcpublishing.com/gray/5ORNVHIZ6FHUHL74IGLVZ6RU4Q.jpg "New York jury holds drug firm Teva liable in opioid crisis")
New York jury holds drug firm Teva liable in opioid crisis
Layoffs To Deepen As Teva Unveils New Structure And Leadership Changes - Pharmaceutical Processing World
TEVA | Teva- Pharmaceutical Industries Stock Price
Teva enters opioid settlement agreement with US state Rhode Island
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report | Fierce Pharma
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
Teva Stock: Sales Miss As Obstacles Continue To Mount | Investor's Business Daily
Teva Pharmaceuticals Q4 2016 Earnings
Teva boss hits out at opioid lawsuits | Financial Times
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Teva Pharmaceutical - Haaretz Com
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Buy Teva Pharmaceuticals amid positive news, Bernstein says
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Jobs with Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals - Wikipedia
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
